Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Improved Survival of Patients with Multiple Myeloma after the Introduction of Novel Agents and the Applicability of the International Staging System (ISS) An Analysis of the Greek Myeloma Study Group (GMSG)

Efstathios Kastritis, Konstantinos Zervas, Argiris Symeonidis, Evangelos Terpos, Sossana Delimpassi, Nicolaos Anagnostopoulos, Evridiki Michali, Athanasios Zomas, Irini Katodritou, Dimitra Gika, Anastasia Pouli, Dimitrios Christoulas, Maria Roussou, Theofanis Economopoulos, Meletios A Dimopoulos

Blood (2008) 112 (11): 655.

https://doi.org/10.1182/blood.V112.11.655.655

Published: 2008

Journal Articles

The International Prognostic Scoring System for Waldestrom’s Macroglobulinemia (ISSWM) Is Applicable in Patients Treated with Rituximab-Based Regimens.

Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis, MD, Dimitra Gika, Sossana Delimpassi, MD, Konstantinos Zervas, MD, Argiris Simeonidis, MD, Evangelos Eleftherakis-Papaiakovou, MD, Nicolaos Anagnostopoulos, MD, Evridiki Michali, MD, Marie Christine Kyrtsonis, MD, Evangelos Terpos, MD, Gerassimos Pangalis, MD

Blood (2007) 110 (11): 3615.

https://doi.org/10.1182/blood.V110.11.3615.3615

Published: 2007

Journal Articles

Treatment of Light Chain (AL) Amyloidosis and Light Chain Deposition Disease (LCDD) with the Combination of Bortezomib and Dexamethasone.

Efstathios Kastritis, MD, Athanasios Anagnostopoulos, MD, Maria Roussou, MD, Savvas Toumanidis, MD, Constantinos Pamboukas, MD, Anna Tassidou, MD, Irini Xilouri, MD, Sossana Delimpassi, MD, Erasmia Psimenou, MD, Sofia Mellou, MD, Evangelos Terpos, MD, John Nanas, MD, Meletios Athanasios Dimopoulos, MD

Blood (2007) 110 (11): 191.

https://doi.org/10.1182/blood.V110.11.191.191

Published: 2007

Journal Articles

High Serum Levels of Angiogenic Cytokines in AL Amyloidosis Correlates with Disease Features.

Efstathios Kastritis, MD, Evangelos Terpos, MD, Mihail Mihail, MD, Konstantinos Anargyrou, MD, Sossana Delimpassi, MD, Marie Christine Kyrtsonis, MD, Evridiki Mihali, MD, Elina Vervessou, MD, Natalia Tzenou, MD, Panagiotis Repoussis, MD, Gerassimos Panagalis, MD, Meletios Athanasios Dimopoulos, MD

Blood (2007) 110 (11): 4781.

https://doi.org/10.1182/blood.V110.11.4781.4781

Published: 2007

Journal Articles

Clinical Characteristics and Outcome of Primary AL Amyloidosis in Greece.

Michalis Michail, MD, Efstathios Kastritis, MD, Sossana Delimpassi, MD, Marie Christine Kyrtsonis, MD, Evridiki Michali, MD, Nicolaos Anagnostopoulos, MD, Konstantinos Zervas, MD, Eirini Katodritou, MD, Panagiotis Panagiotidis, MD, Natalia Tzenou, Gerassimos Pangalis, MD, Meletios Athanasios Dimopoulos, MD

Blood (2007) 110 (11): 4729.

https://doi.org/10.1182/blood.V110.11.4729.4729

Published: 2007

Journal Articles

Symptomatic Waldenstrom’s Macroglobulinemia (WM) in Young Patients: Disease Characteristics and Outcome.

Efstathios Kastritis, MD, Evangelos Eleftherakis-Papaiakovou, MD, Magdalini Migkou, MD, Dimitra Gika, Evangelos Terpos, MD, Konstantinos Zervas, MD, Marie Christine Kyrtsonis, MD, Nicolaos Anagnostopoulos, MD, Sossana Delimpassi, MD, Argiris Symeonidis, MD, Meletios Athanasios Dimopoulos, MD

Blood (2007) 110 (11): 4730.

https://doi.org/10.1182/blood.V110.11.4730.4730

Published: 2007

NARROW

Improved Survival of Patients with Multiple Myeloma after the Introduction of Novel Agents and the Applicability of the International Staging System (ISS) An Analysis of the Greek Myeloma Study Group (GMSG)

The International Prognostic Scoring System for Waldestrom’s Macroglobulinemia (ISSWM) Is Applicable in Patients Treated with Rituximab-Based Regimens.

Treatment of Light Chain (AL) Amyloidosis and Light Chain Deposition Disease (LCDD) with the Combination of Bortezomib and Dexamethasone.

High Serum Levels of Angiogenic Cytokines in AL Amyloidosis Correlates with Disease Features.

Clinical Characteristics and Outcome of Primary AL Amyloidosis in Greece.

Symptomatic Waldenstrom’s Macroglobulinemia (WM) in Young Patients: Disease Characteristics and Outcome.

Email alerts

ASH Publications

American Society of Hematology

Improved Survival of Patients with Multiple Myeloma after the Introduction of Novel Agents and the Applicability of the International Staging System (ISS) An Analysis of the Greek Myeloma Study Group (GMSG)

The International Prognostic Scoring System for Waldestrom’s Macroglobulinemia (ISSWM) Is Applicable in Patients Treated with Rituximab-Based Regimens.

Treatment of Light Chain (AL) Amyloidosis and Light Chain Deposition Disease (LCDD) with the Combination of Bortezomib and Dexamethasone.

High Serum Levels of Angiogenic Cytokines in AL Amyloidosis Correlates with Disease Features.

Clinical Characteristics and Outcome of Primary AL Amyloidosis in Greece.

Symptomatic Waldenstrom’s Macroglobulinemia (WM) in Young Patients: Disease Characteristics and Outcome.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only